These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 10955785

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Isolated hepatic perfusion with high-dose melphalan results in immediate alterations in tumor gene expression in patients with metastatic ocular melanoma.
    Varghese S, Xu H, Bartlett D, Hughes M, Pingpank JF, Beresnev T, Alexander HR.
    Ann Surg Oncol; 2010 Jul; 17(7):1870-7. PubMed ID: 20221901
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].
    Kettelhack C, Hohenberger P, Schlag PM.
    Dtsch Med Wochenschr; 1997 Feb 14; 122(7):177-81. PubMed ID: 9072487
    [Abstract] [Full Text] [Related]

  • 9. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
    Cornett WR, McCall LM, Petersen RP, Ross MI, Briele HA, Noyes RD, Sussman JJ, Kraybill WG, Kane JM, Alexander HR, Lee JE, Mansfield PF, Pingpank JF, Winchester DJ, White RL, Chadaram V, Herndon JE, Fraker DL, Tyler DS, American College of Surgeons Oncology Group Trial Z0020.
    J Clin Oncol; 2006 Sep 01; 24(25):4196-201. PubMed ID: 16943537
    [Abstract] [Full Text] [Related]

  • 10. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver.
    Alexander HR, Bartlett DL, Libutti SK, Fraker DL, Moser T, Rosenberg SA.
    J Clin Oncol; 1998 Apr 01; 16(4):1479-89. PubMed ID: 9552055
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma.
    Hayes AJ, Neuhaus SJ, Clark MA, Thomas JM.
    Ann Surg Oncol; 2007 Jan 01; 14(1):230-8. PubMed ID: 17066234
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study.
    van Etten B, Brunstein F, van IJken MG, Marinelli AW, Verhoef C, van der Sijp JR, Guetens G, de Boeck G, de Bruijn EA, de Wilt JH, Eggermont AM.
    Ann Surg Oncol; 2004 Jun 01; 11(6):598-605. PubMed ID: 15172933
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of in-transit metastases from cutaneous melanoma by isolation perfusion with tumour necrosis factor-alpha (TNF-alpha), melphalan and interferon-gamma (IFN-gamma). Dose-finding experience at the National Cancer Institute of Milan.
    Vaglini M, Santinami M, Manzi R, Inglese MG, Santoro N, Persiani L, Belli F.
    Melanoma Res; 1994 Mar 01; 4 Suppl 1():35-8. PubMed ID: 8038594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.